DJ Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slid 2.97% to $364.65 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.10% to 50,188.14 and the S&P 500 Index falling 0.33% to 6,941.81.
This was the stock's second consecutive day of losses.
Amgen Inc. closed 5.32% short of its 52-week high of $385.12, which the company reached on February 6th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.12% to $238.35, Pfizer Inc. $(PFE)$ rose 2.07% to $27.61, and AbbVie Inc. $(ABBV)$ fell 0.37% to $222.44.
Trading volume (3.5 M) eclipsed its 50-day average volume of 2.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 10, 2026 16:33 ET (21:33 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments